Recent Event

<>

April 19, 2017

Podcast

Locust Walk Biotalk

Speaker: Roger Longman

Real Endpoints LLC

In this episode of BioTalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Roger Longman, CEO of Real Endpoints, about the pricing and reimbursement issues that are affecting the biopharmaceutical industry, with a particular focus on the impact on deal making. Highlights of the conversation include:

  • Major shifts in the pharmaceutical industry in recent decades
  • Why pharmaceutical pricing and reimbursement became such a ‘hot button’ topic
  • Trends towards value-based pricing and ‘pay for performance’ approaches
  • Recent high profile product launches and pricing decisions
  • Implications of pricing / reimbursement environment on life science deal making and business development.
view event >

Recent Events

April 27, 2025 - May 1, 2025

Las Vegas, NV

The Real Endpoints team will be on the ground for Asembia’s AXS25 Summit April 27 – May 1 to discuss market access, pricing and contracting, and patient support services.

view event >

April 28, 2024 - May 2, 2024

Las Vegas, NV

ASX24

The Real Endpoints team will be on the ground for Asembia’s AXS24 Summit April 28 – May 2 to discuss market access, pricing and contracting, and patient support services.

April 15, 2024 - April 17, 2024

Cambridge, UK

Jeff Berkowtiz, CEO

The ABI conference is an annual invitation-only gathering of industry leaders, scientists and inventors, and innovators that alternates between Cambridge UK and Cambridge US. On April 16, CEO Jeff Berkowitz will present a talk, “Paying for Innovation.”

view event >

April 15, 2024 - April 18, 2024

New Orleans, LA

Rob O'Brien, SVP Specialty

On April 17, Rob O’Brien will join payers and thought leaders at this year’s annual AMCP meeting to discuss prescription digital therapeutics and how to prepare for coverage.

view event >

January 7, 2024

San Francisco, CA

Jeff Berkowitz, CEO

Real Endpoints

Real Endpoints CEO, Jeff Berkowitz to be participating in the Sachs NIF at JPM24. Given the level of innovation in CNS, it’s a timely discussion.

view event >

November 17, 2023

Chicago, IL

Rob O'Brien, SVP Specialty

A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.

view event >